Suchergebnisse - "Nivolumab"

PubPharm (9.396)

1

Brief Report : Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von McNamee, N. | Harvey, C. | Gray, L. | +19

2

Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD-L1 and PD-L2

enthalten in: Head & neck | 2024

von Sato, R. | Komatsuda, H. | Inoue, T. | +8

3

Association Between Kidney Function and Outcomes Following Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Carcinoma

enthalten in: Clinical genitourinary cancer | 2024

von Ishihara, H. | Nemoto, Y. | Tachibana, H. | +9

4

First-line immunotherapy of metastatic renal cell carcinoma : an updated network meta-analysis including triplet therapy

enthalten in: BJU international | 2024

von Yanagisawa, T. | Kawada, T. | Bekku, K. | +11

5

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer : a phase Ib trial and ctDNA analyses

enthalten in: Nature medicine | 2024

von Kelly, R. | Landon, B. | Zaidi, A. | +28

6

REVOLUMAB : A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Picca, A. | Touat, M. | Belin, L. | +13

7

Discordant PD-L1 results between 28-8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kim, H. | Shin, J. | Song, I. | +4

8

Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients

enthalten in: Japanese journal of clinical oncology | 2024

von Ohba, K. | Nakanishi, H. | Kawada, K. | +5

9

Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma : A systematic review and network meta-analysis

enthalten in: International immunopharmacology | 2024

von Wang, S. | Lv, H. | Yu, J. | +1

10

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Haakensen, V. | Öjlert, �. | Thunold, S. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[940]